World Investment Advisors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$345K Sell
6,784
-215
-3% -$11.1K 0.01% 1141
2026
Q1
$356K Sell
6,999
-63
-0.9% -$2.94K 0.01% 1158
2025
Q4
$208K Sell
7,062
-5,236
-43% -$142K ﹤0.01% 1376
2025
Q3
$318K Buy
+12,298
New +$343K 0.01% 964
2025
Q2
Sell
-9,262
Closed -$263K 1181
2025
Q1
$263K Buy
9,262
+2,163
+30% +$76.8K 0.01% 915
2024
Q4
$295K Buy
+7,099
New +$339K 0.01% 827

Other funds holding MRNA

World Investment Advisors's MRNA Position: Q2 2026 in Review

World Investment Advisors reduced its Moderna (MRNA) stake by 3.1% in Q2 2026, selling an estimated $11.1K and leaving 6,784 shares worth $345K. The position accounts for 0.01% of the portfolio, ranked #1141.

World Investment Advisors first reported a position in MRNA in Q4 2024 and has held it in 6 quarters since. The position peaked at $356K in Q1 2026. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • World Investment Advisors held 6,784 shares of Moderna worth $345K as of Q2 2026.
  • World Investment Advisors sold 215 Moderna shares in Q2 2026, an estimated $11.1K.
  • Moderna made up 0.01% of World Investment Advisors's portfolio in Q2 2026, its #1141 holding.
  • World Investment Advisors first reported a position in Moderna in Q4 2024 and has held it in 6 quarters since.
  • World Investment Advisors's Moderna position peaked at $356K in Q1 2026.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.